
AlphaTau
Alpha Tau Medical focuses on research, development and commercialization of Alpha DaRT for the treatment of solid cancer tumors.
Market cap
$286m
Enterprise value
$219m
Share price
$3.36 DRTS
Company register number
515344539
Authorizing premium user...